TMEM14A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.223200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.143200E-01
Normal-vs-Stage2
6.726000E-01
Normal-vs-Stage3
7.146800E-01
Normal-vs-Stage4
4.250600E-01
Stage1-vs-Stage2
7.884000E-01
Stage1-vs-Stage3
1.227830E-01
Stage1-vs-Stage4
4.647800E-01
Stage2-vs-Stage3
3.148800E-01
Stage2-vs-Stage4
3.271400E-01
Stage3-vs-Stage4
1.699640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.247800E-01
Normal-vs-AfricanAmerican
5.861000E-01
Normal-vs-Asian
9.430400E-01
Caucasian-vs-AfricanAmerican
9.975600E-01
Caucasian-vs-Asian
4.412400E-01
AfricanAmerican-vs-Asian
5.711000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.796600E-01
Normal-vs-Female
6.909400E-01
Male-vs-Female
2.680200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.369400E-01
Normal-vs-Age(41-60Yrs)
5.461800E-01
Normal-vs-Age(61-80Yrs)
6.814400E-01
Normal-vs-Age(81-100Yrs)
4.989000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.458000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.683600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.057200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.183400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.456600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.044200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.590600E-01
Normal-vs-Daily Drinker
8.552800E-01
Normal-vs-Weekly Drinker
9.684800E-01
Normal-vs-Occasional Drinker
2.489400E-01
Normal-vs-Social Drinker
9.654200E-01
Non Drinker-vs-Daily Drinker
1.087010E-01
Non Drinker-vs-Weekly Drinker
2.903400E-01
Non Drinker-vs-Occasional Drinker
5.101700E-02
Non Drinker-vs-Social Drinker
2.810400E-01
Daily Drinker-vs-Weekly Drinker
6.704200E-01
Daily Drinker-vs-Occasional Drinker
6.220100E-03
Daily Drinker-vs-Social Drinker
6.581800E-01
Weekly Drinker-vs-Occasional Drinker
2.600100E-02
Weekly Drinker-vs-Social Drinker
9.952600E-01
Occasional Drinker-vs-Social Drinker
2.240300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.240100E-02
Normal-vs-Grade 2
1.214230E-02
Normal-vs-Grade 3
3.790100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.465200E-01
Grade 1-vs-Grade 3
8.796000E-01
Grade 1-vs-Grade 4
4.240100E-02
Grade 2-vs-Grade 3
7.654800E-01
Grade 2-vs-Grade 4
1.214230E-02
Grade 3-vs-Grade 4
3.790100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.855600E-01
Normal-vs-NonDiabetic
5.577200E-01
Diabetic-vs-NonDiabetic
1.727820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.532600E-01
Normal-vs-NoPancreatitis
5.854600E-01
Pancreatitis-vs-NoPancreatitis
1.695570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.536800E-01
Normal-vs-N1
6.957400E-01
N0-vs-N1
2.056800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.147600E-01
Normal-vs-TP53-NonMutant
5.043400E-01
TP53-Mutant-vs-TP53-NonMutant
8.425400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
